SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-20-013457
Filing Date
2020-04-08
Accepted
2020-04-08 10:51:51
Documents
2
Period of Report
2020-03-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1472
2 POWER OF ATTORNEY (PUBLIC): EXHIBIT 24 - POWER OF ATTORNEY doc1.txt EX-24 3829
  Complete submission text file 0001127602-20-013457.txt   6691
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703
Business Address
Doyle Anthony (Reporting) CIK: 0001808688 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23186 | Film No.: 20781397